Markers that predict omalizumab response identified

May 2, 2016

(HealthDay)—Baseline serum periostin levels and levels of serum free immunoglobulin E (IgE) during treatment follow-up may be useful in assessing response to omalizumab treatment for asthma, according to a study published online April 26 in Allergy.

Tomoko Tajiri, from Kyoto University in Japan, and colleagues assessed the utility of biomarkers of type 2 inflammation (free serum IgE levels) in predicting omalizumab responses. Response was defined as the absence of asthma exacerbation during the first year of treatment. The study included 30 patients who were treated with omalizumab for at least one year, with 27 of them treated for two years.

The researchers found that patients without exacerbations during the first year of treatment had significantly higher baseline serum periostin levels and blood eosinophil counts than patients with exacerbations. There was a negative association between baseline serum periostin levels, but not eosinophil counts, and free serum IgE levels after 16 or 32 weeks of treatment. Reduced exacerbation numbers at two years were seen in those with reduced free serum IgE levels during treatment. For the 14 who had exacerbations during the first year of treatment, exacerbation numbers gradually and significantly decreased over the two-year study period, with simultaneous significant reductions in free serum IgE levels.

"Baseline serum periostin levels and serum free IgE levels during treatment follow-up may be useful in evaluating responses to omalizumab treatment," conclude the authors.

Several authors report financial ties to the pharmaceutical industry. One author disclosed a patent application for serum periostin for treatment of bronchial asthma.

Explore further: Preventive topical steroids cut atopic dermatitis severity

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Preventive topical steroids cut atopic dermatitis severity

April 28, 2016
(HealthDay)—Intermittent preventive administration of topical corticosteroids in children controls the severity of atopic dermatitis (AD), according to a study published online April 14 in the Journal of Dermatology.

Omalizumab decreases colds in inner-city children with asthma, study reports

March 6, 2016
Treatment with omalizumab significantly decreases the number of colds in inner-city children with allergic asthma, researchers reported at a press conference today at the American Academy of Allergy, Asthma and Immunology ...

Elevated carcinoembryonic antigen described in anorexia

March 30, 2016
(HealthDay)—In a case report published online March 25 in the International Journal of Eating Disorders, elevated serum carcinoembryonic antigen (CEA) levels are observed in a male patient with anorexia nervosa (AN).

Vitamin D deficiency ups odds of asthma exacerbation

December 5, 2014
(HealthDay)—Vitamin D deficiency is associated with increased odds of asthma exacerbations, according to a study published in the December issue of Allergy.

Investigational treatment provides hope for some chronic liver disease sufferers

April 16, 2016
A new study presented today provides hope for a new treatment in patients with primary sclerosing cholangitis, a rare condition characterised by inflammation and scarring in the bile ducts of the liver and for which there ...

Serotonin levels low in ankylosing spondylitis

October 3, 2015
(HealthDay)—Patients with ankylosing spondylitis (AS) have lower serotonin levels than healthy controls and patients with rheumatoid arthritis (RA), according to a study published online Sept. 30 in the Journal of Bone ...

Recommended for you

Study reveals new therapeutic target for slowing the spread of flu virus

June 22, 2018
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, Ph.D., ...

First ancient syphilis genomes decoded

June 21, 2018
An international research team, including scientists from the Max Planck Institute for the Science of Human History, the University of Tübingen, the National School of Anthropology and History in Mexico City, and the University ...

Rhesus macaque model offers route to study Zika brain pathology

June 21, 2018
Rhesus macaque monkeys infected in utero with Zika virus develop similar brain pathology to human infants, according to a report by researchers at the California National Primate Research Center and School of Veterinary Medicine ...

California Aedes mosquitoes capable of spreading Zika

June 21, 2018
Over the last five years, Zika virus has emerged as a significant global human health threat following outbreaks in South and Central America. Now, researchers reporting in PLOS Neglected Tropical Diseases have shown that ...

Breakthrough treatment for crippling jaw disease created

June 20, 2018
A first-ever tissue implant to safely treat a common jaw defect, known as temporomandibular joint dysfunction, has been successfully tested by UCI-led researchers in a large animal model, according to new findings.

New flu vaccine only a little better than traditional shot

June 20, 2018
A newer kind of flu vaccine only worked a little bit better in seniors this past winter than traditional shots, the government reported Wednesday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.